Heart Transplant Donor Selection Guidelines: Review and Recommendations

Shyama Sathianathan1, Geetha Bhat2

  • 1School of Medicine, Penn State College of Medicine, 500 University Dr, Hershey, PA, 17033, USA. sys5817@psu.edu.

Current Cardiology Reports
|February 18, 2022
PubMed

Insights

Heart transplant demand outstrips supply, necessitating expanded donor criteria. This review examines extended donor selection, including donation after circulatory death, to improve outcomes and address donor shortages.

Area of Science:

  • Cardiology
  • Transplant Surgery
  • Immunology

Background:

  • Heart transplant waiting lists exceed donor availability, driving the need for expanded donor criteria.
  • Current institutional criteria for identifying marginal donors vary significantly, impacting donor pool utilization.
  • Advancements like donation after circulatory death (DCD) necessitate re-evaluation of established donor selection protocols.

Purpose of the Study:

  • To review current literature on extended donor criteria for heart transplantation.
  • To analyze the impact of donor selection on heart transplant outcomes.
  • To propose a model for optimizing donor heart selection.

Main Methods:

  • Systematic literature review of studies on extended donor criteria in heart transplantation.
  • Analysis of International Society of Heart and Lung Transplant (ISHLT) 2020 report findings.
  • Evaluation of newer donor types, including donation after circulatory death (DCD).

Main Results:

  • Existing literature supports and challenges the ISHLT 2020 report's emphasis on donor selection criteria.
  • Predictive models from international databases show limited efficacy in predicting individual center outcomes.
  • Donor risk factors and their association with transplant success require further investigation.

Conclusions:

  • Optimizing donor selection is crucial for improving heart transplant outcomes.
  • Standardized and updated criteria for extended and DCD donors are needed.
  • Further research into donor risk factor associations will refine donor heart selection models.
Abstract

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
69
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
551
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
86
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
537